These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27905519)

  • 81. Analysis of CDK12 alterations in a pan-cancer database.
    Pan E; Cabal A; Javier-DesLoges J; Patel D; Panian J; Lee S; Shaya J; Nonato T; Xu X; Stewart T; Rose B; Shabaik A; Cohen E; Kurzrock R; Tamayo P; McKay RR
    Cancer Med; 2022 Feb; 11(3):753-763. PubMed ID: 34898046
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient's CDK12 Mutation: A Case Report.
    Zhu S; Bao Y; Zheng L; Zhao J; Chen Y; Huang R; Sun G; Zhao F; Zhang X; Liang J; Chen J; Wang Z; Ni Y; Chen N; Shen P; Zeng H
    Onco Targets Ther; 2022; 15():947-952. PubMed ID: 36082136
    [No Abstract]   [Full Text] [Related]  

  • 83. Pathogenicity of PKCγ Genetic Variants-Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer.
    Shahid K; Khan K; Badshah Y; Mahmood Ashraf N; Hamid A; Trembley JH; Shabbir M; Afsar T; Almajwal A; Abusharha A; Razak S
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672978
    [TBL] [Abstract][Full Text] [Related]  

  • 84. CDK12 inactivation across solid tumors: an actionable genetic subtype.
    Marshall CH; Imada EL; Tang Z; Marchionni L; Antonarakis ES
    Oncoscience; 2019 May; 6(5-6):312-316. PubMed ID: 31360735
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion.
    Tien JF; Mazloomian A; Cheng SG; Hughes CS; Chow CCT; Canapi LT; Oloumi A; Trigo-Gonzalez G; Bashashati A; Xu J; Chang VC; Shah SP; Aparicio S; Morin GB
    Nucleic Acids Res; 2017 Jun; 45(11):6698-6716. PubMed ID: 28334900
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Progress in PARP inhibitors beyond BRCA mutant recurrent ovarian cancer?
    González Martín A
    Lancet Oncol; 2017 Jan; 18(1):8-9. PubMed ID: 27908593
    [No Abstract]   [Full Text] [Related]  

  • 87. Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in
    Kim H; George E; Ragland R; Rafail S; Zhang R; Krepler C; Morgan M; Herlyn M; Brown E; Simpkins F
    Clin Cancer Res; 2017 Jun; 23(12):3097-3108. PubMed ID: 27993965
    [No Abstract]   [Full Text] [Related]  

  • 88. Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
    Isono M; Hoffmann MJ; Pinkerneil M; Sato A; Michaelis M; Cinatl J; Niegisch G; Schulz WA
    J Exp Clin Cancer Res; 2017 Jan; 36(1):1. PubMed ID: 28049532
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
    Swisher EM; Lin KK; Oza AM; Scott CL; Giordano H; Sun J; Konecny GE; Coleman RL; Tinker AV; O'Malley DM; Kristeleit RS; Ma L; Bell-McGuinn KM; Brenton JD; Cragun JM; Oaknin A; Ray-Coquard I; Harrell MI; Mann E; Kaufmann SH; Floquet A; Leary A; Harding TC; Goble S; Maloney L; Isaacson J; Allen AR; Rolfe L; Yelensky R; Raponi M; McNeish IA
    Lancet Oncol; 2017 Jan; 18(1):75-87. PubMed ID: 27908594
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Screening of gene mutations associated with bone metastasis in nonsmall cell lung cancer.
    Zhang K; Zhang M; Zhu J; Hong W
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C186-C190. PubMed ID: 28230015
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Polymorphisms of DNA Repair Genes in Thyroid Cancer.
    Gielecińska A; Kciuk M; Kołat D; Kruczkowska W; Kontek R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892180
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies.
    Molinaro C; Martoriati A; Cailliau K
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359720
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging.
    Chon HS; Sehovic M; Marchion D; Walko C; Xiong Y; Extermann M
    J Cancer; 2019; 10(12):2604-2618. PubMed ID: 31258768
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Integrative molecular characterization of Chinese prostate cancer specimens.
    Lv SD; Wang HY; Yu XP; Zhai QL; Wu YB; Wei Q; Huang WH
    Asian J Androl; 2020; 22(2):162-168. PubMed ID: 31134918
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Increased single-strand annealing rather than non-homologous end-joining predicts hereditary ovarian carcinoma.
    Deniz M; Romashova T; Kostezka S; Faul A; Gundelach T; Moreno-Villanueva M; Janni W; Friedl TWP; Wiesmüller L
    Oncotarget; 2017 Nov; 8(58):98660-98676. PubMed ID: 29228718
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oxoaporphine Metal Complexes (Co
    Qin JL; Shen WY; Chen ZF; Zhao LF; Qin QP; Yu YC; Liang H
    Sci Rep; 2017 Apr; 7():46056. PubMed ID: 28436418
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer.
    Guffanti F; Fruscio R; Rulli E; Damia G
    Sci Rep; 2016 Dec; 6():38142. PubMed ID: 27905519
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.
    Zhao Q; Yang J; Li L; Cao D; Yu M; Shen K;
    J Gynecol Oncol; 2017 Jul; 28(4):e39. PubMed ID: 28541631
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
    Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
    Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.